Animal experiments have good medical progress due to the conflicting results, caused by species-variation, they provide. Here are some examples: BLOOD TRANSFUSION: BLOOD GROUPS AND TYPING "According to the Report of the Royal Commission on Vivisection (1912): The first human blood-transfusion was made by Andre Libavius in 1594 when, for a large reward, the blood of a young man was passed into the veins of an older man.
Modern technique depends upon a careful matching of blood-types, and no animal experiments have, or could have helped in this essential particular."(Hans Ruesch, One Thousand Doctors (and many more) Against Vivisection, page 131.) The following information is taken from Cardiac Arrest by Emil Levin, M.D. and Diane Danielson. "The French physician, Jean Denis, transfused lambs' blood into numerous patients who all died.
Not recognizing the basic differences between animals and humans, Denis did not realize why his technique failed. Yet, because of the failure of this animal experiment, no further attempts were made for more than a century."(K. Walker, The Story of Medicine, Hutchinson, 1954. R. McGrew, Encyclopedia of Medical History, MacMillan Press, 1985. A. Gastiglioni, A History of Medicine, (1947 edition translated by E.
B. Krumbhaer) Ryerson Press, 1941.) The identification of the various blood groups by Karl Landsteiner, an Australian emigrant who was awarded a Nobel Prize for his achievement, which permitted safe blood transfusions, was a result of direct observation of humans.(J.E. Schmidt, Medical Discoveries Who and When, Charles C. Thomas, 1959. P. Levine and R.E. Stetson, FAMA, Vol. 113, 1939, pages 126-127.
) Antibiotics "Clinical Medical Discoveries by Dr M. Beddow Bayly, M.R.C.S., L.R.C.P. outlines a brief history of the discovery and application, by human observations, of antibiotic penicillin until the advent of Prof. A. Fleming and Sir Howard Florey, who carried out all their initial experiments in vitro. More recently Dr Robert Sharpe, basing his article on Clinical Pharmacology and Therapeutics by T.
Koppanyi and M.A. Avery, Vol. 7, 1966, pages 250-270, agreed with a report made by Hans Ruesch in Naked Empress (or the Great Medical Fraud) that Fleming, being worried that penicillin might be de-activated by blood, injected a sample into rabbits, which died. Discouraged he abandoned penicillin until Oxford scientists Florey and Chain resurrected it for further tests. Being out of stock of the usual guinea-pigs on the day of the trials they used mice which it cured and penicillin was acclaimed.
Later trials with guinea-pigs proved fatal, even with tiny amounts. Another coincidence occurred when Fleming was reluctant to inject penicillin into the spine of a critically-ill patient and Florey tried it on cats. As the patient was near death with insufficient time to observe the cats Fleming took a gamble and administered the penicillin. The patient lived and the cats died. Thus humans received penicillin despite the erroneous and inconclusive trials with animals which almost resulted in its rejection and abandonment.
Despite its apparent success, evidence shows that the discovery of antibiotics might have been a devil in disguise. In Slaughter of the Innocent Hans Ruesch reveals reports from many doctors and medical institutions warning that antibiotics weaken the organisms while strengthening the various strains of bacteria to such an extent that some of them eventually defy every type of antibiotic. Ruesch points out that by the end of the 1940s antibiotics were so overprescribed that the result was the production of stronger and stronger bacteria, and weaker and weaker human beings.
By the 1950s various hospitals registered outbreaks of epidemics that no antibiotic was able to cure. Brian Inglis reported that in the U.S. there were "over a hundred such epidemics in a single year, of which one killed 22 patients in a Texas hospital". When the medical authorities argued that the use of antibiotics was justified in spite of the recognised damage, John Lear, former science editor of the Saturday Review wrote in a "miracle drugs" article about a study made by Charles Henry Kempe, University of Chicago medical researcher, as follows: "The record shows that prophylactic antibiotics do more harm than good.
Dr Kempe’s study cited in this connection the result of a 250 ‘clean’ operation. Of the 154 not subjected to prophylactic antibiotics only 7.8% developed bacterial aftermath. The remaining 96 patients all received prophylactic antibiotics, of which 37.5% were subjected to bacterial complications." " Smallpox "Although the notion of inoculation against smallpox had been around for over 1000 years, it was Edward Jenner who revived the idea in the late 18th century.
Smallpox inoculation was allowed until a fierce outbreak of the disease occurred in 1838, when the practice was banned under threat of imprisonment. Smallpox then declined steadily until, in 1867, vaccination was enforced by law, on all children. Then began the largest epidemic ever in Britain, with a peak of 42,000 deaths per year. Leicester and Dewsbury rejected the serum and relied on effective measures, hygiene and sanitation.
Consequently these towns had the lowest death rate in the country. Walter R. Hadwen, a vegetarian doctor became First Prizeman in Physiology, Operative Surgery, Pathology, Forensic Medicine and in 1891 won the Clark Scholarship for "distinguished medical student of the year". He became famous nationwide when he eradicated an epidemic of smallpox in Gloucester by ruling out all vaccination and introducing strict measures of hygiene and isolation of the infected.
In 1910 he accepted the Presidency of the British Union for the Abolition of Vivisection, a position he retained until his death." Polio http://www.health.org.nz/polio.html Ten years earlier, in 1973, Prof. Clausen, Director of the Institute of Preventative Medicine at the University of Odense, Denmark, warned the medical establishment: "Millions of people have been inoculated with anti-polio vaccine contaminated with tumoral SV40 virus.
" (Present in the green monkey cells ground to produce the vaccine.) "It is possible that it will take 20 or more years before the eventual harmful effects of the vaccine will manifest itself." "In 1941, Dr. Albert Sabin studied human autopsies to finally disprove the nasal theory. He found the virus confined to the gastrointestinal tract, as had been documented nearly 30 years earlier. Sabin later denounced the monkey model blunder: '.
.. prevention was long delayed by the erroneous conception of the nature of the human disease based on misleading experimental models of the disease in monkeys.'" Smallpox "Although the notion of inoculation against smallpox had been around for over 1000 years, it was Edward Jenner who revived the idea in the late 18th century. Smallpox inoculation was allowed until a fierce outbreak of the disease occurred in 1838, when the practice was banned under threat of imprisonment.
Smallpox then declined steadily until, in 1867, vaccination was enforced by law, on all children. Then began the largest epidemic ever in Britain, with a peak of 42,000 deaths per year. Leicester and Dewsbury rejected the serum and relied on effective measures, hygiene and sanitation. Consequently these towns had the lowest death rate in the country. Walter R. Hadwen, a vegetarian doctor became First Prizeman in Physiology, Operative Surgery, Pathology, Forensic Medicine and in 1891 won the Clark Scholarship for "distinguished medical student of the year".
He became famous nationwide when he eradicated an epidemic of smallpox in Gloucester by ruling out all vaccination and introducing strict measures of hygiene and isolation of the infected. In 1910 he accepted the Presidency of the British Union for the Abolition of Vivisection, a position he retained until his death." Rubella Australian Dr Glen Dettman reports that the failure rate of the vaccine alone would be grounds for concern, but the evidence of damage done by the vaccine is much more worrying as "one third of individuals suffering from rheumatoid arthritis have live rubella viruses in their joints".
An article in J.I.D., Vol. 151, 1985, pages 330-336 reads: "If there has been an inadequate immune response after vaccination, as often happens, there is a pronounced danger that the person will become a carrier of rubella as well as developing arthritis and an enlarged thyroid." Any reasonably diligent investigator will find it easy to turn up evidence opposing ARSL's claims. All one requires is time and a little patience.
All vaccines and modern drugs are developed on laboratory animals... therefore on fraud. Small wonder that the end result is heavy with catastrophe. The following comments are from a battery of prestigious sources, all impeccably qualified to make them: "As the Department of Health and Social Security prepares its campaign on rubella vaccination, the Spastics Society maintains that the nine-year-old rubella prevention programming has not yet made any great impact on the number of women whose babies may be affected by maternal rubella in early pregnancy, has remained essentially unaltered", the Society's report says.
"There is no evidence that fewer congenital rubella babies are being born now than ten years ago, and there are still large numbers of women who are vulnerable to rubella. The programme has failed and the future does not look hopeful."(The Lancet, May 5 1979.) "Trials on rubella vaccine in the USA have shown a failure rate of 93%."(Here's Health, April 1980.) "An 80% failure rate amongst Army recruits was noted by Dr Beverley Allan of the Austin Hospital, Melbourne.
"(Australian Nurse's Journal, May 1987.) "Thirty-two women who had either been vaccinated against rubella, or who had been screened and found immune, when they became pregnant all contracted rubella. Nineteen chose to have their babies, only one child had a birth defect. The other 13, brain-washed by the rubella vaccine cartel, had abortions."(British Medical Journal, November 16 1987.) "The Nobel Laureate, Dr John Enders, has suggested that the rubella vaccine makes it more likely that young girls will contract the disease when they grow up.
"(Patrick Rattigan, Blood Poison (Vaccination Explained), June 1990.) HEART TRANSPLANT Covered in Chapter 14 Kidney Disease, Organ Transplants and Dialysis. Dr M.H. Pappworth, eminent London physician and internationally known teacher of clinical medicine, wrote: "The public should know that transplant surgery never cures the original disease and never makes the recipient a healthy person... All transplant surgery is a confession of failure, of unsuccessful early diagnosis and treatment.
"(Hans Ruesch, One Thousand Doctors (and many more) Against Vivisection, page 98.) Experiments on dogs to develop transplant techniques were disastrous. Hundreds of dogs were used yet the first human patients died because of complications which arose when the technique was applied to the first human patients.(Dr Albert Iben, Stanford University cardiac surgeon reported in the Erie Daily Times, May 23 1968.
) By 1980, 65% of patients survived more than a year as a result of increased skill gained through clinical experience.(Lancet, March 29 1980, pages 687-688.) MONITORING EEG The electroencephalograph is not a result of animal experimentation.(M. Beddow Bayly, Clinical Medical Discoveries, NAVS, 1961.) FLOATING CARDIAC CATHETER Dr Forssman used his own forearm to develop cardiac catheterization and his technique was completed through clinical trials with human patients.
(M. Beddow Bayly, Clinical Medical Discoveries, NAVS, 1961.) THE CAGED BALL VALVE Doctors Starr and Edward almost discarded the caged ball valve as it killed all their experimental dogs. It was however successful on human beings.(A. Starr, "Mitral Replacement: Clinical Experience with a Ball-Valve Prosthesis", Annals of Surgery, 154(4):740, 1961.) VENTILATION OF OPEN THORAX Doctors Ivan Magill and E.
S. Rowbotham, working with World War I casualties at Sir Harold Gillie's plastic surgery hospital in Sidcup, Great Britain developed the technique of delivering anaesthetic gas through a single endotracheal tube under positive pressure controlled by the patient's breathing. They performed no animal experiments.(R.G. Richardson, The Surgeon's Heart: A History of Cardiac Surgery, William Heinemann Medical Books Ltd, page 101.
) DEFIBRILLATION Fibrillation of the ventricles is life-threatening. Reverend John Wesley in the 18th Century through clinical observations successfully used electrotherapy to stop fibrillation in human patients. More than a century later in 1899 Presost and Batteli "re-proved" what Wesley had developed, by using electric shock to reverse ventricular fibrillation in dogs. William B. Kouwenhoven of Johns Hopkins University is sometimes credited by pro-vivisectionists for developing a closed-chest defibrillator for dogs and then for human use in 1957.
However clinician Dr P. Zoll had developed closed-chest resuscitation on patients in 1956. Once again Kouwenhoven repeated what Zoll had discovered through human observations and falsely credited animal research for the advance.(L. Wertenbaker, To Mend the Heart, the Viking Press, 1980, page 178.); (J.H. Comroe, Exploring the Heart: Discoveries in Heart Disease and High Blood Pressure, W.W. Norton and Company, 1983, page 159.
); (L.E. Meltzer, Textbook of Coronary Care, The Charles Press Publishers Inc., A Prentice Hall Company, 1980, page 4.) ELECTIVE CARDIAC ARREST For "restarting" the heart once again animal experiments gave misleading results. Though a technique was shown "effective" in animals, it was discarded for use in humans because of "many problems, consisting of pain, burns and inability to keep up continuous stimulation for a prolonged period".
(W. Lillihei, "The Treatment of Complete Heart Block by the Combined Use of a Myocardial Electrode and an Artificial Pacemaker", Surgical Forum, 43rd Clinical Congress, Vol. VII, American College of Surgeons, Chicago, 1957.) MYOCARDIAL PRESERVATION TECHNIQUES Scientists at the Middlesex Hospital and Medical School recently isolated individual heart cells from human heart muscle. These cells are useful in research into heart disease and in the preservation of heart (myocardial) tissue for cardiac surgery, with the advantage that results are directly applicable to patients because as the researchers stated: ".
.. it is difficult and often misleading to extrapolate experimental results in animal tissues to man."(T. Powell, et al, BMF, October 17 1981, pages 1013-1014.) THE PACEMAKER Each of the techniques made to contract or stimulate the ventricles in attempts to "pace" the human heart was tested on dogs and shown "effective", even heralded as a success, however they were "quickly discarded in patients because of the many problems, consisting of pain, burns and inability to keep up continuous stimulation for the prolonged period".
Dr C. Walton Lillihei pioneer of the pacemaker, seeing his method which was developed on dogs fail to cross the species, devised, through observing his patients, a method of "stitching electrodes directly on to the heart, leading them through the chest and running a pulsed current through them". "The development of artificial pacemakers for complete heart block grew out of direct studies of human patients suffering from ventricular septal defect.
"(W. Lillihei, "The Treatment of Complete Heart Block by the Combined Use of a Myocardial Electrode and an Artificial Pacemaker", Surgical Forum, 43rd Clinical Congress, Vol. VIII, American College of Surgeons, Chicago, 1957, page 360.) Also refer L. Wertenbaker, To Mend the Heart, The Viking Press, 1980, page 181; and R.G. Richardson, The Surgeon's Heart: A History of Cardiac Surgery, William Heinemann Medical Books Ltd, page 101.
OPEN-HEART SURGERY The heart-lung machine was the most critical development in open-heart surgery for it takes over the function of the patient's heart and lungs during open heart operations. John H. Gibbon of Philadelphia, U.S.A. who developed a heart-lung machine on dogs abandoned his project when two patients died, admitting that it was unsafe for human beings. J.W. Kirklin of the Mayo Clinic, without the use of animals and using careful clinical trials made a heart-lung machine which was successful on human beings.
(H. McLeave, The Risk Takers, Holt, Rinehard & Winston, 1962, page 70.) "Results from animal experiments in the 1960s suggested that there might be important advances in transplantation and there-by prompted a large amount of further research into heart and kidney transplants in rats. But tissue differences between humans and rats proved that animal experiments were once again misleading. The encouraging results had raised hopes that a major advance in clinical immunosuppression for transplantation was in the offing, but these hopes have now faded and nothing of the great mass of work has been translated into clinical practice.
"[John Fabre of Oxford's Nuffield Department of Surgery, Transplantation, Vol. 34, 1982, pages 223-234.]] --------------------------- The foundation for biomedical research!? Are you having a laugh? They are a lobby group for the vivisection industry. They are hardly going to say otherwise. It was known 200 years ago how to innoculate against smallpox. And even further back in history they knew about it in India.
It was known that microbes caused disease. It became known - hundreds of years ago - that weakened strains of microbes could protect against disease. Who tried to find things without vivisection? No one, I'll bet. Those people just reached for the nearest mouse of dog, just as they had been trained to do. We have to take their word for it that there was no other way. I wouldn't take their word if it was gift wrapped.
The fact is that the vivisection/pharmaceutical world order have been caught again and again cheating, lying, corrupting and passing money under the table. Nothing they say can be relied upon as the truth. They have hidden data, claimed that researchers wrote studies when they didn't, and hidden whole trials because the data was too hot to try to massage. They have corrrupted regulators, governments and scientists.
They have deliberately put human lives in danger. Deliberately and willingly.See Also: Knitted Stuffed Animal Patterns
The zoo are going to be an excellent option put if you want to receive animals pics without having acquiring a visit to safari in summer time. You may just take their shots during the safe bench which is available in the vicinity of the cages. To make you success in getting the images of animals that you would like, you are able to adhere to the next ideas.
From a jungle of rain-washed pines and junipers spearing the recent blueness from the Florida sky, ran a little, tawny-haired boy. His bare feet, extending from his overalled legs, crackled against the fallen palmettos. He leaped in to the air, flinging his arms toward a flock of white doves circling earlier mentioned him.
According to the U.S. Food and Drug Administration (FDA), a medical device is “an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including a component part, or accessory which is: recognized in the official National Formulary, or the United States Pharmacopoeia, or any supplement to them intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals, or intended to affect the structure or any function of the body of man or other animals, and which does not achieve any of its primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of any of its primary intended purposes.
” All medical devices have a unique and thorough set of testing requirements enforced by the FDA, China Food and Drug Administration (CFDA), EU Notified Bodies, and other regulatory bodies that need to be fulfilled before entering the marketplace. NAMSA is a respected medical device contract research organization (CRO), and the world’s only medical research organization (MRO) with 50 years of experience with medical device, IVD, regenerative medicine and combination product testing.
We follow the standards set by the device industry; in fact, we help set them. In other words, we not only do medical device testing, we are the definitive industry source in medical device testing. NAMSA accelerates our client’s medical devices through integrated regulatory, toxicology, microbiology, chemistry, clinical and quality services to ensure the device will get to market in a safe, effective and timely manner.
Our ability to apply unique combinations of specialties to assist our clients has helped guide us to become more than just a CRO. We are a medical research organization; whether you are performing Materials Characterization or Preclinical Biocompatibility Testing, NAMSA has well-equipped testing facilities, vivariums, surgical teams and Technical Specialists located worldwide with the expertise to get your product through a comprehensive testing program.
For more information regarding our facility locations, please visit our NAMSA’s locations page. Materials Characterization and Analytical Chemistry Materials Characterization and Analytical Chemistry testing defines the components that make up a medical device, confirming its identity and enabling assessment of reproducibility in manufacturing and processing. Using our deep knowledge of science and regulation, we offer an extensive range of these testing services to help secure product safety, quality and consistency during all stages of development.
Some of our capabilities include, but are not limited to: Physiochemical Testing Fourier Transform Infrared Spectroscopy (FTIR) Thermal Analysis High Performance Liquid Chromatography Extractables and Leachables Spectroscopic Assays (UV/VIS,IR) Preclinical Studies Preclinical Studies are executed to test and verify the intended performance of a medical device, IVD or regenerative medicine product.
Our experts use a broad range of in vivo models and analysis tools, and comply with methods and regulations described by the European Committee for Standardization (CEN), US Food and Drug Administration (FDA) and other applicable guidelines to provide our clients with accurate results. These studies include: Cardiovascular Cadaveric Non-Clinical Testing Dental Drug Delivery Gastroenterology Specialized Pathology Services Neurosurgery and Spine Surgery Ophthalmology Orthopedic and Bone Healing Physician Training Tissue Engineering Urogenital System Wound Healing Safety Studies Reconstructive and General Surgery Biocompatibility Testing Our preclinical testing facilities and vivariums are specially designed for the conduct of in vitro and in vivo safety evaluation studies on a variety of biomaterials, medical devices, and combination products.
These types of tests are performed to identify the presence of toxins or any other potentially harmful effects. Biocompatibility testing ranges from the initial screening of new materials to product release testing, periodic audit testing, and non-clinical or pre-market safety evaluations to meet current FDA and international standards. Some of these Biocompatibility tests include, but are not limited to: Cytotoxicity Sensitization Irritation Genotoxicity Implantation Histopathology Sterility Assurance and Microbiology Testing Microbiology testing identifies microorganisms and their impacts on other living organisms and sterility testing assures the absence of viable contaminating microorganisms.
NAMSA’s facilities contain laboratories for microbiology and sterility testing as well as aging chambers. Sterility Assurance and Microbiology tests we conduct include, but are not limited to: Sterilization Validation Environmental Monitoring Packaging Validation and Shelf Life Testing Reusable Device Studies Antimicrobial Testing Disinfection Studies Are NAMSA’s medical device testing services a good fit for your needs? Contact a NAMSA representative +1-866-666-9455 (+1-419-666-9455 if you’re outside the US) or through our site contact form.